Pds biotech to announce third quarter financial results on november 14, 2024 at 8:30 a.m. eastern time

Princeton, n.j., nov. 06, 2024 (globe newswire) -- pds biotechnology corporation (nasdaq: pdsb) (“pds biotech” or the “company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers and the development of infectious disease vaccines, today announced that the company will host a conference call to report financial results for the quarter ended september 30, 2024, and provide a clinical program update on thursday, november 14, 2024, at 8:30 a.m. eastern time.
PDSB Ratings Summary
PDSB Quant Ranking